Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
2010 · BMC Gastroenterology · 199 citations
https://doi.org/10.1186/1471-230x-10-40
P
Pascal Lebray
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
167
Papers
7.2K
Citations
39
h-index
73
i10-index
Pascal Lebray is an academic researcher from Sorbonne Université. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Hepatitis B Virus Studies. The author has an h-index of 39, co-authored 142 publications.
ORCID: 0000-0001-8719-6533Papers by this author
worksFrom congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?
2021 · JHEP Reports · 36 citations
https://doi.org/10.1016/j.jhepr.2021.100249
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial
2025 · Lupus Science & Medicine · 1 citations
https://doi.org/10.1136/lupus-2024-001435
FRI-259 A real-life multidisciplinary clinic approach for the management of metabolic dysfunction associated steatotic liver disease
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01486-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat